GB1101458A - Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs - Google Patents

Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs

Info

Publication number
GB1101458A
GB1101458A GB1192665A GB1192665A GB1101458A GB 1101458 A GB1101458 A GB 1101458A GB 1192665 A GB1192665 A GB 1192665A GB 1192665 A GB1192665 A GB 1192665A GB 1101458 A GB1101458 A GB 1101458A
Authority
GB
United Kingdom
Prior art keywords
myotic
pharmaceutical compositions
local anaesthetics
synergistic pharmaceutical
neurotropic drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1192665A
Inventor
Jean Chibret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories Merck Sharp and Dohme Chibret SAS
Original Assignee
Laboratoires Chibret SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Chibret SA filed Critical Laboratoires Chibret SA
Priority to GB1192665A priority Critical patent/GB1101458A/en
Publication of GB1101458A publication Critical patent/GB1101458A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pharmaceutical preparations comprise at least one of the following:-procaine, tetracaine, lignocaine, cinchocaine, benodaine, pilocarpine and at least one hydrolysis product derived from the acid moiety of a p-amino-benzoic acid ester, e.g. sodium p-amino-benzoate.
GB1192665A 1965-07-20 1965-07-20 Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs Expired GB1101458A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1192665A GB1101458A (en) 1965-07-20 1965-07-20 Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1192665A GB1101458A (en) 1965-07-20 1965-07-20 Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs

Publications (1)

Publication Number Publication Date
GB1101458A true GB1101458A (en) 1968-01-31

Family

ID=9995187

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1192665A Expired GB1101458A (en) 1965-07-20 1965-07-20 Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs

Country Status (1)

Country Link
GB (1) GB1101458A (en)

Similar Documents

Publication Publication Date Title
BE873326A (en) ANTI-CANCER AND PREVENTIVE MEDICINE FOR CANCERIOUS METASTASES
GB1101458A (en) Synergistic pharmaceutical compositions comprising local anaesthetics, myotic and neurotropic drugs
ATA401872A (en) Stabilized pharmaceutical composition containing fluvastatin sodium as active ingredient
GB1049996A (en) New medicine with anti-inflammatory and anti-rheumatic activity
FR2373561A1 (en) CORTICOSTEROIDS AND MEDICINAL PRODUCTS CONTAINING THEM
CA958643A (en) Pharmaceutical compositions containing cyclobenzaprine
PH12135A (en) Anthelmintic pharmaceutical preparations containing 4-(4-nitroanilino)-phenylisothiocyanate
IL37629A0 (en) Pharmaceutical compositions comprising a derivative of hydantoin
IT1150100B (en) PROCEDURE FOR THE PRODUCTION OF SAPPONINE PREPARATIONS HAVING A THERAPEUTIC VALUE AND PRODUCTS SO OBTAINED
BE887320A (en) COMPOSITION AND ANTI-INFLAMMATORY MEDICINAL PRODUCT COMPRISING SUCH A COMPOSITION
IL29954A0 (en) Process for the preparation of morpholine derivatives and pharmaceutical compositions containing them
IL28811A (en) 1,3-disubstituted pyrrolidines,their preparation and pharmaceutical compositions containing them
IL26620A (en) 1,2-dihydroquinoline-n-carboxylic and thionocarboxylic acid esters,their preparation and pharmaceutical compositions containing them
AU414340B2 (en) Medicinal compositions for administration to animals and process for administering same
AU3469468A (en) Medicinal compositions for administration to animals and process for administering same
BE778421A (en) BENZENE-SULFONYL-UREES AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
CA707745A (en) Preparation of a medicinal agent for the treatment of hypercholesterolemia
FR2025033A1 (en) PHENYL-DITHIO-CARBAMIC ACID ESTERS AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
SE7809943L (en) PHARMACOLOGICAL ACTIVE ESTERS, PREPARATIONS FOR PRODUCTS THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH ASSOCIATIONS
GB1099269A (en) New anti-arteriosclerotic compositions
CA726162A (en) Gastro-intestinal therapeutic compositions containing pantothenic acid and method of administration
AU439970B2 (en) Pharmaceutical compositions forthe treatment of nematode infections
IL37700A0 (en) Pharmaceutical preparations containing a propanolamine derivative and an ethanolamine derivative
AU291240B2 (en) Improvements relating tothe production of pharmaceutical dosage units
CA724631A (en) Therapeutic compositions for oral administration